News Archives - Page 7 of 8 - MaxWell Biosystems

Retina study utilizing HD-MEAs (MaxOne) selected as “Best of Neuron”

December 14, 2016

The paper by K. Yonehara*, M. Fiscella*, A. Drinnenberg*, et al. entitled “Congenital Nystagmus Gene FRMD7 is necessary for establishing a neuronal circuit asymmetry for direction selectivity” was chosen for the “Best of Neuron” selection 2015-2016. “Best of Neuron“ includes ground-breaking neuroscience research published in Neuron and is a collection of editors’ and readers’ favorites. MaxWell Biosystems HD-MEA core technology was used in this study, to characterize the disease phenotype discovered in the FRMD7 mutant retina. Mutation in the FRMD7 gene is linked to the…

MaxWell Biosystems wins CHF 20,000 at Venture Kick (Stage 2)

November 10, 2016

Marie Obien

Awards, Grants, News, Startup

MaxWell Biosystems successfully cleared Venture Kick Stage 2 and received CHF 20,000. See Venture Kick news here >> Venture Kick finances start-ups at the early stage with a grant of up to CHF 130,000 and provides professional support of business experts.

MaxWell Biosystems part of the Innovation Village in MipTec 2016

September 20, 2016

Marie Obien

Conference, Exhibit, News

MaxWell Biosystems presented MaxOne at MipTec 2016 in Basel. As one of the events during Basel Life Science Week, over 100 life science companies worldwide gathered at the MipTec International Life Science Exhibition. The MaxWell Biosystems booth was located in the Innovation Village next to other start-up companies. Dr. Michele Fiscella, VP Scientific Affairs, gave daily product presentations on the features and applications of the MaxOne technology.

MaxWell Biosystems in 2016 SPS/JSPS/CSPT Joint Meeting

September 18, 2016

Marie Obien

Cardio, Conference, Exhibit, News

MaxWell Biosystems exhibited MaxOne and its applications for Cardiac Safety Pharmacology at the 2016 Safety Pharmacology Society (SPS) / Japanese Safety Pharmacology Society (JSPS) / Canadian Society of Pharmacology and Therapeutics (CSPT) Joint Meeting in Vancouver, BC, Canada. The meeting, held from the 18th to 21st of September 2016, had over 568 attendees from around the world, with 253 abstracts presented and 51 exhibiting companies.

MaxWell Biosystems officially an ETH spin-off

September 16, 2016

Marie Obien

News, Startup

MaxWell Biosystems received the ETH spin-off label and joins the strong list of ETH spin-off companies. MaxWell Biosystems continues to be in close collaboration with Prof. Dr. Andreas Hierlemann and the Bio Engineering Laboratory, Department of Biosystems Science and Engineering in Basel.

Cookie	Duration	Description
cookielawinfo-checbox-analytics	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics".
cookielawinfo-checbox-functional	11 months	The cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional".
cookielawinfo-checbox-others	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other.
cookielawinfo-checkbox-necessary	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary".
cookielawinfo-checkbox-performance	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance".
viewed_cookie_policy	11 months	The cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data.